| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nuvectis Pharma, Inc.
13G
NVCT · 67080T108
|
5.1% |
8/6/2026
Event 8/4/2026
|
|||
| Soleus Private Equity Fund III, L.P. | 0.5% | ||||
| Soleus Private Equity GP III, LLC | 0.5% | ||||
| Soleus PE GP III, LLC | 0.5% | ||||
| Soleus Capital Master Fund, L.P. | 4.6% | ||||
| Soleus Capital, LLC | 4.6% | ||||
| Soleus Capital Group, LLC | 4.6% | ||||
| Soleus Capital Management, L.P. | 5.1% | ||||
| Soleus GP, LLC | 5.1% | ||||
| Levy Guy | 5.1% | ||||
|
Prelude Therapeutics Inc
13G
PRLD · 74065P101
|
5.2% |
7/8/2026
Event 4/21/2026
|
|||
| Soleus Private Equity Fund III, L.P. | 1.0% | ||||
| Soleus Private Equity GP III, LLC | 1.0% | ||||
| Soleus PE GP III, LLC | 1.0% | ||||
| Soleus Capital Master Fund, L.P. | 4.2% | ||||
| Soleus Capital, LLC | 4.2% | ||||
| Soleus Capital Group, LLC | 4.2% | ||||
| Soleus Capital Management, L.P. | 5.2% | ||||
| Soleus GP, LLC | 5.2% | ||||
| Levy Guy | 5.2% | ||||
|
CalciMedica, Inc.
13G/A
Amendment 4
CALC · 38942Q202
|
2.4% |
5/8/2026
Event 3/31/2026
|
|||
| Soleus Private Equity Fund III, L.P. | 1.2% | ||||
| Soleus Private Equity GP III, LLC | 1.2% | ||||
| Soleus PE GP III, LLC | 1.2% | ||||
| Soleus Capital Master Fund, L.P. | 1.2% | ||||
| Soleus Capital, LLC | 1.2% | ||||
| Soleus Capital Group, LLC | 1.2% | ||||
| Soleus Capital Management, L.P. | 2.4% | ||||
| Soleus GP, LLC | 2.4% | ||||
| Guy Levy | 2.4% | ||||
|
Aprea Therapeutics, Inc.
13G
APRE · 03836J102
|
10.0%
Checked 5% or less
|
4/1/2026
Event 4/1/2026
|
|||
| Soleus Private Equity Fund III, L.P. | 10.0% | ||||
| Soleus Private Equity GP III, LLC | 10.0% | ||||
| Soleus PE GP III, LLC | 10.0% | ||||
| Soleus Capital Master Fund, L.P. | 10.0% | ||||
| Soleus Capital, LLC | 10.0% | ||||
| Soleus Capital Group, LLC | 10.0% | ||||
| Soleus Capital Management, L.P. | 10.0% | ||||
| Soleus GP, LLC | 10.0% | ||||
| Guy Levy | 10.0% | ||||
|
Invivyd, Inc.
13G/A
Amendment 1
IVVD · 00534A102
|
2.8% |
2/12/2026
Event 12/31/2025
|
|||
| Soleus Private Equity Fund III, L.P. | 0.6% | ||||
| Soleus Private Equity GP III, LLC | 0.6% | ||||
| Soleus PE GP III, LLC | 0.6% | ||||
| Soleus Capital Master Fund, L.P. | 2.2% | ||||
| Soleus Capital, LLC | 2.2% | ||||
| Soleus Capital Group, LLC | 2.2% | ||||
| Soleus Capital Management, L.P. | 2.8% | ||||
| Soleus GP, LLC | 2.8% | ||||
| Guy Levy | 2.8% | ||||
|
CalciMedica, Inc.
13G/A
Amendment 3
CALC · 38942Q202
|
7.5% |
11/7/2025
Event 9/30/2025
|
|||
| Soleus Private Equity Fund III, L.P. | 3.8% | ||||
| Soleus Private Equity GP III, LLC | 3.8% | ||||
| Soleus PE GP III, LLC | 3.8% | ||||
| Soleus Capital Master Fund, L.P. | 3.8% | ||||
| Soleus Capital, LLC | 3.8% | ||||
| Soleus Capital Group, LLC | 3.8% | ||||
| Soleus Capital Management, L.P. | 7.5% | ||||
| Soleus GP, LLC | 7.5% | ||||
| Guy Levy | 7.5% | ||||
|
Immunic, Inc.
13G/A
Amendment 1
IMUX · 4525EP101
|
1.6% |
11/7/2025
Event 9/30/2025
|
|||
| Soleus Private Equity Fund III, L.P. | 1.1% | ||||
| Soleus Private Equity GP III, LLC | 1.1% | ||||
| Soleus PE GP III, LLC | 1.1% | ||||
| Soleus Capital Master Fund, L.P. | 0.5% | ||||
| Soleus Capital, LLC | 0.5% | ||||
| Soleus Capital Group, LLC | 0.5% | ||||
| Soleus Capital Management, L.P. | 1.6% | ||||
| Soleus GP, LLC | 1.6% | ||||
| Guy Levy | 1.6% | ||||
|
Invivyd, Inc.
13G
IVVD · 00534A102
|
5.1% |
10/14/2025
Event 10/10/2025
|
|||
| Soleus Private Equity Fund III, L.P. | 1.3% | ||||
| Soleus Private Equity GP III, LLC | 1.3% | ||||
| Soleus PE GP III, LLC | 1.3% | ||||
| Soleus Capital Master Fund, L.P. | 3.7% | ||||
| Soleus Capital, LLC | 3.7% | ||||
| Soleus Capital Group, LLC | 3.7% | ||||
| Soleus Capital Management, L.P. | 5.1% | ||||
| Soleus GP, LLC | 5.1% | ||||
| Guy Levy | 5.1% | ||||
|
Verastem, Inc.
13G/A
Amendment 4
VSTM · 92337C203
|
1.8% |
5/2/2025
Event 3/31/2025
|
|||
| Soleus Private Equity Fund III, L.P. | 0.7% | ||||
| Soleus Private Equity GP III, LLC | 0.7% | ||||
| Soleus PE GP III, LLC | 0.7% | ||||
| Soleus Capital Master Fund, L.P. | 1.2% | ||||
| Soleus Capital, LLC | 1.2% | ||||
| Soleus Capital Group, LLC | 1.2% | ||||
| Soleus Capital Management, L.P. | 1.8% | ||||
| Soleus GP, LLC | 1.8% | ||||
| Guy Levy | 1.8% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.